6785 昱展新藥本益比(PER)
| 年度/月份 | 本益比(倍) | 月收盤價 |
|---|
| 2026/05 | -520.37 | 140.50 |
| 2026/04 | -542.59 | 146.50 |
| 2026/03 | -614.81 | 166.00 |
| 2026/02 | -816.67 | 220.50 |
| 2026/01 | -998.15 | 269.50 |
| 2025/12 | -1125.93 | 304.00 |
| 2025/11 | -961.11 | 259.50 |
| 2025/10 | -977.78 | 264.00 |
| 2025/09 | -868.52 | 234.50 |
| 2025/08 | -822.22 | 222.00 |
| 2025/07 | 2920.00 | 146.00 |
| 2025/06 | 2780.00 | 139.00 |
| 2025/05 | 2990.00 | 149.50 |
| 2025/04 | 470.37 | 127.00 |
| 2025/03 | 477.78 | 129.00 |
| 2025/02 | 551.85 | 149.00 |
| 2025/01 | 17.87 | 126.00 |
| 2024/12 | 20.07 | 141.50 |
| 2024/11 | 22.70 | 160.00 |
| 2024/10 | 22.71 | 166.00 |
| 2024/09 | 24.83 | 181.50 |
| 2024/08 | 28.66 | 209.50 |
| 2024/07 | 27.12 | 195.00 |
| 2024/06 | 34.77 | 250.00 |
| 2024/05 | 39.64 | 285.00 |
| 2024/04 | 40.76 | 273.50 |
| 2024/03 | 45.08 | 302.50 |
| 2024/02 | 64.98 | 436.00 |
| 2024/01 | -471.55 | 273.50 |
| 2023/12 | - | - |
| 2023/11 | - | - |
| 2023/10 | - | - |
| 2023/09 | - | - |
| 2023/08 | - | - |
| 2023/07 | - | - |
| 2023/06 | - | - |
| 2023/05 | - | - |
| 2023/04 | - | - |
| 2023/03 | - | - |
| 2023/02 | - | - |
| 2023/01 | - | - |
| 2022/12 | - | - |
| 2022/11 | - | - |
| 2022/10 | - | - |
| 2022/09 | - | - |
| 2022/08 | - | - |
| 2022/07 | - | - |
| 2022/06 | - | - |
| 2022/05 | - | - |
| 2022/04 | - | - |
| 2022/03 | - | - |
| 2022/02 | - | - |
| 2022/01 | - | - |
| 2021/12 | - | - |
| 2021/11 | - | - |
| 2021/10 | - | - |
| 2021/09 | - | - |
| 2021/08 | - | - |
| 2021/07 | - | - |
| 2021/06 | - | - |
| 2021/05 | - | - |
| 2021/04 | - | - |
| 2021/03 | - | - |
| 2021/02 | - | - |
| 2021/01 | - | - |